SOLVE M.E. President and CEO Emily Taylor, Chief Scientific Officer H. Timothy Hsiao, and Director of Advancement Ilise Friedman recently visited Yale School of Medicine’s Center for Infection & Immunity (CII), the Center Director, Sterling Professor Akiko Iwasaki, PhD, and her research team, as coordinated by Dr. Nicole Darricarrère, CII’s Scientific Program Director, in New Haven, CT. The SOLVE delegation honored Professor Iwasaki with an award to recognize her contributions to the study of infection-associated chronic conditions and illnesses, and delivered an invited talk to the Iwasaki Lab to elaborate the power of the SOLVE Together Real-World Platform to accelerate biomedical research for post-acute infection syndromes, such as ME/CFS and Long Covid. Watch a video of the presentation here.
Following the formal presentation, the SOLVE delegation was treated with an informative tour of the Iwasaki Lab. Through interactive dialogues, the Iwasaki Lab and SOLVE discussed opportunities for collaborative research in the future, especially on improving precision subtyping and harnessing wearable technologies to better include into research people who suffer the most severe forms of ME/CFS or Long Covid.
“Prof. Iwasaki is among the most brilliant and compassionate minds in science of our time. Based on the positive feedback we received from Prof. Iwasaki and her team, we are excited for the prospect of synergizing with the Iwasaki Lab’s research excellence through our SOLVE Together Real-World Data platform to collaboratively enable more comparative studies across conditions and advance precision medicine,” said H. Timothy Hsiao, a Yale alum himself.
Dr. Iwasaki was recently named one of the 100 Most Influential People of 2024 by TIME magazine, and is the President of the American Association of Immunologists.
SOLVE has previously supported Dr. Iwasaki’s collaborators, including Dr. David Putrino’s ongoing clinical study (recording of the SOLVE-hosted webinar can be found here), and a Ramsay Research Grant to Aaron Ring, MD, PhD, for the project “Discovery of Pathological Autoantibodies in ME/CFS and Post-Acute Sequelae of SARS-CoV-2 Infection.”
The SOLVE Together Real-World Data platform is the largest of its kind for ME/CFS and Long Covid in the U.S. Anyone above the age of 18 residing in the United States can create an account to join. Learn more and join at: https://solvecfs.org/research/solve-together/.
You Can Support Solve’s Innovative Research Programs!
SOLVE M.E. invests in translational research, meaning research that transforms an idea into a study, a study into diagnostics and clinical trials, and clinical trials into approval of available treatments. We fund a portfolio of research projects at some of the most prestigious medical centers and research laboratories in the United States and abroad, and partner with leading experts in the field and build new collaborations. Our patient-centered real-world data platform, SOLVE Together, integrates multiple data sources designed to speed up the discovery of treatments and cures.
But our investment in innovative scientific studies to address knowledge gaps in ME/CFS, Long Covid, and other infection-associated chronic conditions and illnesses is only possible with your support.
Please make a gift to SOLVE today and help us build a better future.